Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant-Reference-Cited by-同舟云学术

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant

Published:2022-05 Issue:5 Volume:84 Page:e64-e66
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

de Michelena Paula,Torres Ignacio,Ramos-García Ángela,Gozalbes Victoria,Ruiz Nidia,Sanmartín Ana,Botija Pilar,Poujois Sandrine,Huntley Dixie,Albert Eliseo,Navarro David

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference11 articles.

1. Rapid diagnostic testing for SARS-CoV-2;Drain;N Engl J Med,2022

2. Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B1.1.7 lineage;Kontogianni;J Infect,2021

3. ARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance;Jian;Int J Infect Dis,2022

4. Comparison of the performance of the panbio COVID-19 antigen test in SARS-CoV-2 B1.1.7 (alpha) variants versus non-B.1.1.7 variants;van Ogtrop;Microbiol Spectr,2021

5. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-COVID-19-tests. 2022.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants;Microbiology Spectrum;2024-07-02

2. Sensitive detection of SARS‐CoV‐2 main protease 3CL^pro with an engineered ribonuclease zymogen;Protein Science;2024-03-19

3. Post-Market Surveillance of Six COVID-19 Point-of-Care Tests Using Pre-Omicron and Omicron SARS-CoV-2 Variants;2024-01-07

4. SERS-based immunoassay on a plasmonic syringe filter for improved sampling and labeling efficiency of biomarkers;The Analyst;2024

5. Perspectives and Prospects on the Application of DNA Aptamer in SARS-CoV-2;Current Medicinal Chemistry;2024-01